These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9112495)

  • 21. Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer.
    Nieuwenhuijzen JA; Horenblas S; Meinhardt W; van Tinteren H; Moonen LM
    BJU Int; 2004 Oct; 94(6):793-7. PubMed ID: 15476510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer.
    Fokdal L; Høyer M; Meldgaard P; von der Maase H
    Radiother Oncol; 2004 Aug; 72(2):139-45. PubMed ID: 15297133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treated natural history of high risk superficial bladder cancer: 15-year outcome.
    Cookson MS; Herr HW; Zhang ZF; Soloway S; Sogani PC; Fair WR
    J Urol; 1997 Jul; 158(1):62-7. PubMed ID: 9186324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
    Zelefsky MJ; Marion C; Fuks Z; Leibel SA
    J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI; Tsolos C; Touloupidis S
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients.
    Wang Y; Cummings B; Catton P; Dawson L; Kim J; Ringash J; Wong R; Yi QL; Brierley J
    Radiother Oncol; 2005 Nov; 77(2):126-32. PubMed ID: 16216364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
    Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.
    Mori K; Nomata K; Noguchi M; Eguchi J; Hayashi N; Kanetake H
    Int J Urol; 2007 Jul; 14(7):591-4. PubMed ID: 17645599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
    Hoskin P; Rojas A; Saunders M
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1425-31. PubMed ID: 19036531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.